| Article

Despite the existence of stringent regulatory controls, clinicians are prescribing potentially lethal fentanyl products to patients who should not be receiving them. So concludes a study from the Johns Hopkins Bloomberg School of Public Health published earlier this week in the Journal of the...

Subscribe to fentanyl

Sign Up

Subscribe to the PAINWeek Newsletter
and get our latest articles and more directly in your inbox.